[CLSTR]
< Back to situations

[ORGANIZATION]

Samsung Biologics

Featured in 19 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [KR] [US] [JP]

South Korea AI chip volatility and semiconductor expansion

289 clusters · 700 sources · last updated

Latest: South Korean KOSPI index snaps winning streak

The AI-memory surge and subsequent market volatility evolved through July and August 2026. Following a period of significant sell-offs, the KOSPI saw a massive single-day gain of roughly 18% on July 31, driven by Samsung

[ACTIVE] [BUSINESS] [KR] [CH] [US]

South Korean biotechnology industry expansion

2 clusters · 4 sources · last updated

Latest: South Korean biotech firms secure spots in top 10 APAC pharma deals

South Korean pharmaceutical companies are transitioning from technology followers to global leaders through the development of blockbuster drugs and significant international acquisitions. Initial projections indicate t

[ACTIVE] [BUSINESS] [US]

Cell and gene therapy industry development

2 clusters · 4 sources · last updated

Latest: Cell and gene therapy manufacturing market projected to reach $212.8 billion by 2030

The cell and gene therapy (CGT) sector is shifting its focus from scientific validation toward overcoming logistical, economic, and manufacturing hurdles. Initially, industry discussions centered on the need for integrat

[QUIET] [BUSINESS] [AU] [SG] [CN]

Asia-Pacific financial market activity

2 clusters · 4 sources · last updated

Latest: Asia-Pacific equity sales poised to break 2021 records

Asia-Pacific financial markets are experiencing significant activity across investment management and capital raising. Family offices in the region are increasingly diversifying their portfolios by raising hedge fund all

[QUIET] [BUSINESS] [KR] [FI] [FR]

South Korea youth employment crisis and policy responses

21 clusters · 39 sources · last updated

Latest: South Korean youth fear retirement age extension will reduce new hiring

In mid-2026, South Korea’s labor market exhibited a deepening demographic divide. While total employment rose by 108,000 year-on-year in July, the youth population (ages 15–29) saw 191,000 fewer employed persons. The you

[QUIET] [BUSINESS] [KR] [US]

Biopharmaceutical manufacturing expansion in Songdo

2 clusters · 7 sources · last updated

Latest: Daewoong Pharmaceutical opens advanced biopharmaceutical facility in Songdo

Biopharmaceutical manufacturing capacity is expanding within the Songdo Bio Cluster in South Korea. Celltrion has renewed its European Medicines Agency (EMA) Good Manufacturing Practice (EU-GMP) certification for its d

[QUIET] [BUSINESS] [CA] [KR] [IT]

BIX 2026 biotechnology convention in South Korea

2 clusters · 4 sources · last updated

Latest: Canada named Country of Honor for BIX 2026 biotechnology convention

The BIOPLUS-INTERPHEX KOREA 2026 (BIX 2026) biotechnology and pharmaceutical convention is scheduled for October 28 to 30 at COEX in Seoul. Supported by the Ministry of Trade, Industry and Resources, the event is expecte

[QUIET] [BUSINESS] [KR]

South Korean brand reputation rankings

4 clusters · 5 sources · last updated

Latest: Korea Intellectual Property Center ranks first in brand reputation

In September 2026, the Korea Institute of Corporate Reputation and the Korea Enterprise Reputation Research Institute released brand reputation rankings for various sectors in South Korea based on big data analysis. Ini

[QUIET] [BUSINESS] [KR] [DE] [FR]

Celltrion biosimilar market expansion

4 clusters · 6 sources · last updated

Latest: Celltrion's Remsima reaches number one in Japan's infliximab market

Celltrion continues to expand its global biosimilar market share, particularly in autoimmune and oncology treatments. In the United States, the ustekinumab biosimilar Stekyma reached a 16.2% market share in July, marking

[QUIET] [BUSINESS] [KR] [PH]

Samsung STEM education and talent initiatives

2 clusters · 2 sources · last updated

Latest: Samsung opens STEM competition for Filipino students

Samsung has implemented various initiatives to support STEM education and talent development across different regions. In South Korea, Samsung Electronics, Samsung Biologics, and Samsung Bioepis awarded scholarships to

[QUIET] [BUSINESS] [KR]

Incheon biotechnology workforce development

2 clusters · 4 sources · last updated

Latest: Songdo Bio-process Training Center begins full operations

Incheon’s biotechnology sector is focusing on specialized workforce development to support its growing industrial ecosystem. An initial survey of 119 local biotech companies revealed a significant demand for advanced tra

Also covered in